A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia
Clinical trial NCT06649214 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06649214
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2026-04-01
- Enrollment
- 654
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.